The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in 4Q Updated U.S. VYJUVEK label expands eligible patient population and provides ...

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

Alvotech ( ($ALVO) ) has issued an update. On November 2, 2025, Alvotech announced that the U.S. FDA issued a complete response letter for its ...

LBS Centre for Science and Technology; Palayam, Nandavanam, has invited applications for the State Eligibility Test (SET), January 2026. SET is an eligibility test for selection as higher secondary ...

Vancouver, Canada, Oct. 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S. Food and Drug ...

These five ventures embody a unique form of entrepreneurship, where founders develop solutions focused on environmental ...

Pharmaceutical company Eli Lilly and Company—or Lilly—announced its plans to build a $6.5 billion manufacturing facility at Generation Park at a news conference Sept. 23.